The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
18 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,348,611 in first-year total cost, median $189,334.
Most frequent study sections
- Special Emphasis Panel[ZRG1 OBT-J (55)]10
- Special Emphasis Panel[ZRG1 OBT-Z (55)]8
Most frequent institutions
- H. LEE MOFFITT CANCER CTR & RES INST2
- UNIVERSITY OF SOUTH FLORIDA2
- CLEVELAND CLINIC LERNER COM-CWRU1
- NORTH CAROLINA CENTRAL UNIVERSITY1
- ROSWELL PARK CANCER INSTITUTE CORP1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | A New Raman-based Strategy to Identify Tumor Margins and Guide Surgical Resection1R21CA184608-01A1 | ZAVALETA, CRISTINA L. | STANFORD UNIVERSITY, CA | $228,068 | ZRG1 |
| 2015 | Gene-Targeted Apoptosis as a Treatment for HER2-Positive Breast Cancer1R21CA185192-01A1 | ROGERS, FAYE A | YALE UNIVERSITY, CT | $217,283 | ZRG1 |
| 2015 | Improving adoptive cell therapy by enhancing T cell longevity1R21CA188767-01A1 | DIAZ-MONTERO, CLAUDIA MARCELA | CLEVELAND CLINIC LERNER COM-CWRU, OH | $206,843 | ZRG1 |
| 2015 | Role of inflammatory microenvironment in Helicobacter-induced gastric cancer1R21CA188752-01A1 | OBONYO, MARYGORRET | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $202,275 | ZRG1 |
| 2015 | Optimization and Efficacy of Covalent Ire-1 RNase Inhibitors in CLL1R21CA199553-01 | DEL VALLE, JUAN R | UNIVERSITY OF SOUTH FLORIDA, FL | $187,475 | ZRG1 |
| 2015 | Manipulating collagen density and structure to prevent breast cancer metastasis1R21CA185216-01A1 | PERRY, SETH | UNIVERSITY OF ROCHESTER, NY | $166,931 | ZRG1 |
| 2015 | NKT cells with chimeric antigen receptors1R21CA199544-01 | WEBB, TONYA J. | UNIVERSITY OF MARYLAND BALTIMORE, MD | $166,931 | ZRG1 |
| 2015 | Oxidized redox state, a new potential biomarker for prostate cancer progression1R21CA188792-01A1 | CHAISWING, LUKSANA | UNIVERSITY OF KENTUCKY, KY | $164,479 | ZRG1 |
| 2014 | Conferring in vivo metabolic resistance to a highly selective anti-AML agent1R21CA185370-01 | MERINO, EDWARD J | UNIVERSITY OF CINCINNATI, OH | $209,918 | ZRG1 |
| 2014 | Elucidate the role of miR-141 in brain metastasis from breast cancer1R21CA188672-01 | DEBEB, BISRAT G | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $208,800 | ZRG1 |
| 2014 | Role of Androgen Receptor in Bone Metastatic Prostate Cancer Apoptosis and NED1R21CA175798-01A1 | DELK, NIKKI A | UNIVERSITY OF TEXAS DALLAS, TX | $199,665 | ZRG1 |
| 2014 | The Role of SHIP-1 in the Modulation of Immunoregulatory Cells in Pancreatic Canc1R21CA179668-01A1 | GHANSAH, TOMAR | UNIVERSITY OF SOUTH FLORIDA, FL | $195,098 | ZRG1 |
| 2014 | Image-Guided Photodynamic Therapy of Lung Cancer1R21CA176154-01A1 | NWOGU, CHUKWUMERE E. | ROSWELL PARK CANCER INSTITUTE CORP, NY | $190,856 | ZRG1 |
| 2014 | The Role of IRAK-4 in African American Breast Cancer1R21CA185361-01 | KIMBRO, KEVIN SEAN | NORTH CAROLINA CENTRAL UNIVERSITY, NC | $187,811 | ZRG1 |
| 2014 | Role of HDAC6 in the modulation of Immune-related pathways in Melanoma1R21CA184612-01 | VILLAGRA, ALEJANDRO V | H. LEE MOFFITT CANCER CTR & RES INST, FL | $183,244 | ZRG1 |
| 2014 | Transcriptional Regulation of Breast Cancer Metastasis within the Tumor Microenvi1R21CA188799-01 | YATES, CLAYTON | TUSKEGEE UNIVERSITY, AL | $174,049 | ZRG1 |
| 2014 | Molecular mechanisms controlling cell proliferation during tissue turnover and ca1R21CA176114-01A1 | OVIEDO, NESTOR J | UNIVERSITY OF CALIFORNIA, MERCED, CA | $158,992 | ZRG1 |
| 2014 | Impact of BRCA1-mTORC2 interaction on breast cancer response to DNA damage and ch1R21CA184996-01 | WOODS, NICHOLAS TAYLOR | H. LEE MOFFITT CANCER CTR & RES INST, FL | $99,893 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.